Date: 11.6.2021
Summary:
A research group based in Italy has developed a new class of small molecules acting as SERPINA3 inhibitors, which are able to reduce prion protein (PrPSc) accumulation in prion-infected cell lines, thereby representing a new therapeutic treatment against prion and prion-like diseases. They are looking for licence agreements and joint venture agreements with pharma companies and/or financial agreements with investors.
Reference: TOIT20210421001
Country: Italy
Submitted: 6. 11. 2021
Keywords
Technology: Neurology, Brain Research.
Market: Drug delivery and other equipment.
NACE: -
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Animal Biotechnology - Information about Animal Biotechnology
Biotech - International biotech science
Solar panels in your eyeballs: Self-powered bionics are on the way
Nanotweezers manipulate bacteriophages with minimal optical power, a breakthrough for phage therapy